Olga Habarova

Title: Olga Habarova: Innovator in HDAC Inhibitors

Introduction

Olga Habarova is a prominent inventor based in Riga, Latvia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit histone deacetylase (HDAC) activity. With a total of 2 patents, her work is paving the way for new treatments for various medical conditions.

Latest Patents

Habarova's latest patents focus on carbamic acid compounds that comprise a bicyclic heteroaryl group as HDAC inhibitors. These compounds are designed to inhibit HDAC activity, which is crucial in the treatment of conditions such as cancer, psoriasis, and other proliferative diseases. The compounds include specific structural features, such as an unsubstituted or substituted bicyclic heteroaryl group and an acid leader group, which enhance their therapeutic potential. The invention also covers pharmaceutical compositions that utilize these compounds for both in vitro and in vivo applications.

Career Highlights

Olga Habarova is associated with Topotarget UK Limited, where she continues to advance her research and development efforts. Her innovative work in the field of HDAC inhibitors has garnered attention and recognition within the scientific community.

Collaborations

Some of her notable coworkers include Paul W Finn and Ivars Kalvinsh, who have collaborated with her on various projects related to her patents.

Conclusion

Olga Habarova's contributions to the field of HDAC inhibitors represent a significant advancement in pharmaceutical research. Her innovative compounds hold promise for the treatment of serious medical conditions, showcasing her impact as an inventor in the industry.